These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10513458)

  • 1. Olanzapine therapy in elderly patients with schizophrenia.
    Sajatovic M; Perez D; Brescan D; Ramirez LF
    Psychopharmacol Bull; 1998; 34(4):819-23. PubMed ID: 10513458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine in Chinese treatment-resistant patients with schizophrenia: an open-label, prospective trial.
    Chiu NY; Yang YK; Chen PS; Chang CC; Lee IH; Lee JR
    Psychiatry Clin Neurosci; 2003 Oct; 57(5):478-84. PubMed ID: 12950701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine.
    Dossenbach MRK ; Beuzen JN; Avnon M; Belmaker RH; Elizur A; Mark M; Munitz H; Schneidman M; Shoshani D; Kratky P; Grundy SL; Tollefson GD
    Clin Ther; 2000 Sep; 22(9):1021-34. PubMed ID: 11048902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.
    Breier A; Hamilton SH
    Biol Psychiatry; 1999 Feb; 45(4):403-11. PubMed ID: 10071708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific.
    Lee CT; Conde BJ; Mazlan M; Visanuyothin T; Wang A; Wong MM; Walker DJ; Roychowdhury SM; Wang H; Tran PV
    J Clin Psychiatry; 2002 Jul; 63(7):569-76. PubMed ID: 12143912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia.
    Godleski LS; Goldsmith LJ; Vieweg WV; Zettwoch NC; Stikovac DM; Lewis SJ
    J Clin Psychiatry; 2003 Feb; 64(2):119-22. PubMed ID: 12633119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents.
    Kumra S; Jacobsen LK; Lenane M; Karp BI; Frazier JA; Smith AK; Bedwell J; Lee P; Malanga CJ; Hamburger S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):377-85. PubMed ID: 9549958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
    Kinon BJ; Jeste DV; Kollack-Walker S; Stauffer V; Liu-Seifert H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):985-96. PubMed ID: 15380859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.
    Madhusoodanan S; Brenner R; Suresh P; Concepcion NM; Florita CD; Menon G; Kaur A; Nunez G; Reddy H
    Ann Clin Psychiatry; 2000 Mar; 12(1):11-8. PubMed ID: 10798821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 1-year open-label trial of olanzapine in school-age children with schizophrenia.
    Ross RG; Novins D; Farley GK; Adler LE
    J Child Adolesc Psychopharmacol; 2003; 13(3):301-9. PubMed ID: 14642018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
    Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
    Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine for patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study.
    Dursun SM; Gardner DM; Bird DC; Flinn J
    Can J Psychiatry; 1999 Sep; 44(7):701-4. PubMed ID: 10500873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, open-label trial of olanzapine in adolescents with schizophrenia.
    Findling RL; McNamara NK; Youngstrom EA; Branicky LA; Demeter CA; Schulz SC
    J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):170-5. PubMed ID: 12544176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.
    Beasley CM; Hamilton SH; Crawford AM; Dellva MA; Tollefson GD; Tran PV; Blin O; Beuzen JN
    Eur Neuropsychopharmacol; 1997 May; 7(2):125-37. PubMed ID: 9169300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.